STING1 and COVID-19: However, the nanoparticle manganese (nanoMn) adjuvant (also known as STING agonists) have been shown to promote antigen presentation, virus-specific memory T-cell development and host-adaptive immunity, making it an optimum adjuvant for protein-based COVID-19 subunit vaccines (Table 2) (84).